Up next

Autoplay

MRD’s Potential Role in Treating Acute Myeloid Leukemia

0 Views • 07/04/23
Share
Embed
administrator
administrator
Subscribers
0

Harry Erba, MD, PhD; Alexander E. Perl, MD; Eunice Wang, MD; and Jorge E. Cortes, MD, debate the current value of minimal residual disease testing for therapeutic decision-making in acute myeloid leukemia and identify the needs to be addressed before use in standard practice.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay